Insider · CIK 0001192595

TEPPER ROBERT I

Reports to the SEC for 25 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001192595

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+15.7K sh	—	—	15,700
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+13.6K sh	—	—	13,550
2020-05-06	Neon Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−9.74M sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−14K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−18.5K sh	—	—	0
2019-06-25	Neon Therapeutics, Inc.Common StockA Award	Director, 10% Owner	AAward	+18.5K sh	—	—	18,500
2019-06-12	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+15.7K sh	—	—	15,700
2019-06-06	CONSTELLATION PHARMACEUTICALS INCStock Option (right to buy)A Award	Director, 10% Owner	AAward	+13.2K sh	—	—	13,171
2019-06-05	Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+14K sh	—	—	14,000
2018-08-22	CONSTELLATION PHARMACEUTICALS INCX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+51K sh	$1.55	+$79.1K	3,034,083
2018-08-22	CONSTELLATION PHARMACEUTICALS INCWarrant (right to buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−51K sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCC Conversion	Director, 10% Owner	CConversion	+2.71M sh	—	—	2,716,384
2018-07-23	CONSTELLATION PHARMACEUTICALS INCP Purchase	Director, 10% Owner	PPurchase	+267K sh	$15.00	+$4M	2,983,051
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries A Preferred StockC Conversion	Director, 10% Owner	CConversion	−11M sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director, 10% Owner	CConversion	−10.7M sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.09M sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries E Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.29M sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries E-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.11M sh	—	—	0
2018-07-23	CONSTELLATION PHARMACEUTICALS INCSeries F Preferred StockC Conversion	Director, 10% Owner	CConversion	−1M sh	—	—	0
2018-06-29	Neon Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	0 sh	—	—	0
2018-06-29	Neon Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	0 sh	—	—	0
2018-06-29	Neon Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	0 sh	—	—	0
2018-06-29	Neon Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	0 sh	—	—	0
2018-06-19	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+13.6K sh	—	—	13,550
2018-06-08	Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+10.2K sh	—	—	10,182
2017-11-06	Allena Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+2.58M sh	—	—	2,575,964
2017-11-06	Allena Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+215K sh	$14.00	+$3.01M	2,790,964
2017-11-06	Allena Pharmaceuticals, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−6.12M sh	—	—	0
2017-11-06	Allena Pharmaceuticals, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.63M sh	—	—	0
2017-10-04	CTMXCytomX Therapeutics, Inc.S Sale	10% Owner	SSale	−24.8K sh	$24.34	−$603K	29,516
2017-09-19	CTMXCytomX Therapeutics, Inc.S Sale	10% Owner	SSale	−20K sh	$18.00	−$360K	54,293
2017-07-25	KALAKALA BIO, Inc.C Conversion	Director	CConversion	+1.62M sh	—	—	1,621,092
2017-07-25	KALAKALA BIO, Inc. · Series Seed Preferred StockC Conversion	Director	CConversion	−3.68M sh	—	—	0
2017-07-25	KALAKALA BIO, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−2.5M sh	—	—	0
2017-07-25	KALAKALA BIO, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−2.27M sh	—	—	0
2017-07-25	KALAKALA BIO, Inc. · Series B Preferred Stock Warrant (right to buy)C Conversion	Director	CConversion	−174K sh	—	—	0
2017-07-25	KALAKALA BIO, Inc. · Common Stock Warrant (right to buy)C Conversion	Director	CConversion	+33.3K sh	—	—	33,333
2017-07-19	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	12,960
2017-06-29	CTMXCytomX Therapeutics, Inc.S Sale	10% Owner	SSale	−15K sh	$16.00	−$240K	44,777
2017-04-06	Global Blood Therapeutics, Inc.S Sale	10% Owner	SSale	−31.2K sh	$33.23	−$1.04M	229,773
2017-02-01	Jounce Therapeutics, Inc.C Conversion	10% Owner	CConversion	+9.69M sh	—	—	10,230,349
2017-02-01	Jounce Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.05M sh	—	—	3,048,780
2017-02-01	Jounce Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−35.8M sh	—	—	0
2017-02-01	Jounce Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−11.3M sh	—	—	0
2015-02-03	bluebird bio, Inc.J Other	Director, 10% Owner	JOther	−1.22M sh	—	—	0
2015-02-03	bluebird bio, Inc.J Other	Director, 10% Owner	JOther	+301K sh	—	—	300,863
2015-02-03	bluebird bio, Inc.J Other	Director, 10% Owner	JOther	−301K sh	—	—	0
2015-02-03	bluebird bio, Inc.J Other	Director, 10% Owner	JOther	+62.5K sh	—	—	89,017
2014-09-12	bluebird bio, Inc.S Sale	Director, 10% Owner	SSale	−38K sh	$36.59	−$1.39M	1,215,054
2014-09-11	bluebird bio, Inc.S Sale	Director, 10% Owner	SSale	−87K sh	$36.52	−$3.18M	2,329,974

Recent filings

Accepted (ET)
Jul 24/A
TEPPER ROBERT I0001640455-20-000091
SEC(opens sec.gov)
Jun 294
TEPPER ROBERT I0001640455-20-000075
SEC(opens sec.gov)
May 64
TEPPER ROBERT I0001694187-20-000071
SEC(opens sec.gov)
Jun 274
TEPPER ROBERT I0001694187-19-000053
SEC(opens sec.gov)
Jun 134
TEPPER ROBERT I0001640455-19-000060
SEC(opens sec.gov)
Jun 104
TEPPER ROBERT I0000899243-19-016202
SEC(opens sec.gov)
Jun 74
TEPPER ROBERT I0001209191-19-035400
SEC(opens sec.gov)
Aug 244
TEPPER ROBERT I0000899243-18-023214
SEC(opens sec.gov)
Jul 244
TEPPER ROBERT I0000899243-18-020533
SEC(opens sec.gov)
Jul 34
TEPPER ROBERT I0001104659-18-043854
SEC(opens sec.gov)

Companies

Address

C/O THIRD ROCK VENTURES, LLC 29 NEWBURY STREET, 3RD FLOOR

BOSTON, MA, 02116